Ameer develops biomaterials and nanotechnology for regenerative engineering, tissue engineering, medical devices, drug delivery and cell delivery applications.
Advance the biosciences
University Priority
Enhancing Quality of Life
Innovation in the biosciences is essential to helping us live longer and healthier lives.
ÌÇÐÄlogo scientists and researchers deliver cutting-edge treatments and cures through their pathbreaking work in synthetic biology, chemistry, cancer research, public health and more.
With collaboration across schools, campuses and partners such as ÌÇÐÄlogo Medicine, a significant percentage of the University’s research enterprise is dedicated to the biosciences. This page provides a snapshot of the transformative work taking place at ÌÇÐÄlogo.
ÌÇÐÄlogo scientists have been blazing new trails in synthetic biology — an innovative marriage of engineering, physics and biological systems — for nearly two decades. Attracting world-class faculty and a growing NIH funding, CSB was established as a nexus of this emerging field that is poised to transform medicine, energy and more.
QSIB combines engineering, life sciences and medicine to create biocompatible electronics, photonics and microfluidics that merge seamlessly with the human body. QSIB's bioelectronic platforms attach to — or even integrate within — vital organs, unlocking unprecedented diagnostic, therapeutic and surgical possibilities. From advancing clinical care and biomedical research to enhancing athletic performance, fitness and overall wellness, QSIB’s innovations redefine what’s possible for human health and beyond.
Imagine therapies so precise they destroy cancer cells without harming healthy tissue, nanoscale materials that rebuild bone and restore spinal cord function, and “nanosponges” that cleanse oil spills and polluted water without endangering marine life. IIN is turning these possibilities into reality. From revolutionizing energy and the environment to redefining health care, this work in nanotechnology is opening doors to solutions once thought impossible.
Lurie Cancer Center is one of only 57 NCI-designated Comprehensive Cancer Centers, a founding member of the National Comprehensive Cancer Network and a Lead Academic Participating Site in the National Clinical Trials Network. Its strengths include a hematopoietic stem cell transplant program that performs 350+ transplants annually, Illinois’s first and only proton therapy center and OncoSET, a pioneering precision-medicine program.
Meet Some of Our Experts
ÌÇÐÄlogo’s researchers make breakthroughs that advance healthcare for everyone.
With an emphasis on translational medicine, our physician-scientists and engineers are at the forefront of research and discovery.
Rivnay engineers organic and biohybrid bioelectronic materials, devices and systems for interfacing between the complex world of biology and traditional optoelectronics.
McNally researches genetics of cardiovascular and neuromuscular disorders and studies genetic mechanisms responsible for inherited human diseases.
Highlights
Learn about ÌÇÐÄlogo’s leadership in the biosciences.
News
See ÌÇÐÄlogo’s new developments in support of this priority.
New devices mimic complex brain signals, point to more energy-efficient computing
From insects to birds to mammals, communication signals follow a common tempo
New study finds some cultivated flowers can support bees and butterflies
The microbiome produces scents that trigger aggression in mice
New system generates oxygen, sustaining drug-producing cells for weeks
New study finds specialized ‘snow flies’ produce bursts of heat and antifreeze proteins